山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
37期
4-7
,共4页
血液病%单采血小板%血小板输注无效%白细胞滤过
血液病%單採血小闆%血小闆輸註無效%白細胞濾過
혈액병%단채혈소판%혈소판수주무효%백세포려과
blood disorder%apheresis platelet%platelet transfusion refractory%leukocyte filtration
目的:探讨血液病患者单采血小板输注无效( PTR)发生率及其影响因素,为临床正确应用血小板制剂提供指导。方法回顾性分析单采血小板输注的70例患者318例次输注资料,通过计算血小板计数增加指数和血小板恢复百分率结合患者出血状况有无改善,判断血小板输注有效性,并讨论其影响因素及处理措施。结果急性白血病、再生障碍性贫血、骨髓异常综合征和特发性血小板减少性紫癜患者PTR发生率分别为22.1%、25.5%、38.3%和51.2%,四种类型的血液病患者血小板PTR发生率差别有统计学意义(P均<0.05);同种疾病无并发症患者PTR发生率低于有并发症者(P<0.05);无并发症患者PTR发生率随着输注次数的增加而上升(P<0.05)。未过滤白细胞与过滤白细胞患者PTR发生率比较差异有统计学意义( P<0.05)。结论疾病类型、有无并发症等因素影响血液病患者血小板输注的治疗效果,减少并发症、过滤白细胞可提高血小板的输注效果。
目的:探討血液病患者單採血小闆輸註無效( PTR)髮生率及其影響因素,為臨床正確應用血小闆製劑提供指導。方法迴顧性分析單採血小闆輸註的70例患者318例次輸註資料,通過計算血小闆計數增加指數和血小闆恢複百分率結閤患者齣血狀況有無改善,判斷血小闆輸註有效性,併討論其影響因素及處理措施。結果急性白血病、再生障礙性貧血、骨髓異常綜閤徵和特髮性血小闆減少性紫癜患者PTR髮生率分彆為22.1%、25.5%、38.3%和51.2%,四種類型的血液病患者血小闆PTR髮生率差彆有統計學意義(P均<0.05);同種疾病無併髮癥患者PTR髮生率低于有併髮癥者(P<0.05);無併髮癥患者PTR髮生率隨著輸註次數的增加而上升(P<0.05)。未過濾白細胞與過濾白細胞患者PTR髮生率比較差異有統計學意義( P<0.05)。結論疾病類型、有無併髮癥等因素影響血液病患者血小闆輸註的治療效果,減少併髮癥、過濾白細胞可提高血小闆的輸註效果。
목적:탐토혈액병환자단채혈소판수주무효( PTR)발생솔급기영향인소,위림상정학응용혈소판제제제공지도。방법회고성분석단채혈소판수주적70례환자318례차수주자료,통과계산혈소판계수증가지수화혈소판회복백분솔결합환자출혈상황유무개선,판단혈소판수주유효성,병토론기영향인소급처리조시。결과급성백혈병、재생장애성빈혈、골수이상종합정화특발성혈소판감소성자전환자PTR발생솔분별위22.1%、25.5%、38.3%화51.2%,사충류형적혈액병환자혈소판PTR발생솔차별유통계학의의(P균<0.05);동충질병무병발증환자PTR발생솔저우유병발증자(P<0.05);무병발증환자PTR발생솔수착수주차수적증가이상승(P<0.05)。미과려백세포여과려백세포환자PTR발생솔비교차이유통계학의의( P<0.05)。결론질병류형、유무병발증등인소영향혈액병환자혈소판수주적치료효과,감소병발증、과려백세포가제고혈소판적수주효과。
Objective To explore incidence rate and influence factor of apheresis platelet transfusion refractory ( PTR) on patients with blood disorder .Methods The data of 318 infusions for 70 patients subject to apheresis platelet infusion were retrospectively analyzed , by calculating corrected Count increment ( CCI ) and percent platelet recovery ( PPR) and combining hemorrhage improvement condition in patients , the effect of platelet transfusion were determined and influence factors and treatment measures were discussed .Results ①The PTR occurrence rate of acute leukemia (AL), aplastic anemia (AA), bone marrow abnormalities syndrome (MDS) and idiopathic thrombocytopenic purpura (ITP) in patients hit 22.1%, 25.5%, 38.3%and 22.1%respectively, the difference in platelet PTR rate in four types of blood diseases was statistically significant (P<0.05).②The difference was statistically significant when the incidence rate of PTR of patients without complications was compared to that of patients with spices of diseases and complications ( P<0.05).③The incidence rate of PTR in the group of patients without complications rose with the increase in the number of infusions (P<0.05).④The difference was statistically significant when the incidence rate of PTR in the group of patients without the filtration of white blood cells was compared to that in the group of patients with the filtration of white blood cells (P<0.05).Conclusions The disease type, number of infusions, fever, infection, spleen enlargement, DIC and other factors become critical factors affecting the transfusion effect of platelets on patients with blood diseases , and the decrease in the complications and filtration of groups of white blood cells can improve the transfusion efficacy of platelets .